Gut Microbiota and Genetic Markers Drive Neutrophil-Mediated Tumor Suppression in Colorectal Cancer
Colorectal cancer remains one of the most significant challenges in modern oncology, consistently ranking as the third most common cancer…
Probiotics Beyond Diarrhea: Francisco Guarner Highlights New Frontiers in Combating Antibiotic Resistance and Microbiota Dysbiosis
The evolution of modern medicine is inextricably linked to the development and widespread use of antibiotics, which have extended the…
SynBalance Unveils Wake Up Your Core Vision at Vitafoods Europe 2026 Redefining Longevity Through Gut Microbiota Innovation
The global nutraceutical industry gathered in Geneva for Vitafoods Europe 2026, where SynBalance, a leading pioneer in probiotic research, officially…
Gut Microbiota Composition Directly Correlates with Baseline Antiviral Immune Activity and Vaccine Response Potential in Humans
A comprehensive study published in the journal Cell has established a definitive link between the composition of the human gut…
Innovation, markets and portfolio evolution: the new horizons for Sacco System
The global probiotic industry is currently undergoing a paradigm shift, transitioning from a generalized approach to gut health toward a…
SynBalance Srl among the Finalists of the NutraIngredients Awards USA | MicrobiomePost
The selection of SynbActive® ProBeautyShield as a finalist for the prestigious NutraIngredients Awards USA 2026 marks a significant milestone for…
Diet-Driven Probiotic Colonization and Microbial Coexistence: New Insights into the Interaction Between BV9 and the Gut Microbiome
The intricate relationship between the human diet and the microscopic inhabitants of the gastrointestinal tract has long been a focal…
